StockFame
  • Trending News
  • Markets
  • US Markets
  • Indian Stocks
  • Economics
  • Crypto News
Select Page

OneSource Pharma-Hikma get regulatory approval to sell generic Ozempic in Saudi Arabia

by Live mint | February 11, 2026 6:09 pm | Indian Stocks, Market, News

The approval from the Saudi Food and Drug Authority allows the company to enter Saudi Arabia, one of the largest markets for Ozempic and other weight management/loss drugs.

Recent Posts

  • ‘Crude Still Rude’: From Tata Motors to M&M, CLSA Trims Targets Across Auto Stocks
  • HDFC Bank Shares In Focus As Motilal Oswal Maintains Bullish View; Sees Up To 38% Upside — Check Target Price
  • Dhurandhar 2 Box Office Collection, Day 1: Aditya Dhar’s Action Thriller Earns Over Rs 100 Crore
  • Petrol, Diesel Prices On March 20: Check New Rates In Hyderabad, Delhi, Kolkata Ahmedabad, And More
  • Crypto.com layoffs: Company to cut 12% workforce as AI push reshapes operations — all you need to know

About Stockfame

Stockfame is a global media platform delivering bold insights on business, markets, technology, leadership, and entrepreneurship. We bring you research-backed news and sharp analysis to help you stay ahead of the curve.

Quick News Links

  • Crypto News
  • Indian Stocks
  • Latest Posts
  • Market
  • News
  • Trending News
  • US Markets

Contact Us

Reach out to us at:
Phone:  [+91] 9834938257
Email: contact@stockfame.com
For Advertisement, Press Releases, Partnerships or to get backlinks on this website, please e-mail us at contact@stockfame.com

Quick Reads

  • Global market news
  • Crypto Market News
  • Indian Market News
  • Economy News
  • Latest Business News
  • About
  • Terms and Conditions
  • Privacy Policy
  • Website User Agreement
  • Disclaimer
  • Facebook
  • X
  • Instagram
  • RSS
Copyright @StockFame | All Rights Reserved